These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22461187)

  • 1. Low prevalence of work disability in early inflammatory arthritis (EIA) and early rheumatoid arthritis at enrollment into a multi-site registry: results from the catch cohort.
    Mussen L; Boyd T; Bykerk V; de Leon F; Li L; Boire G; Hitchon C; Haraoui B; Thorne JC; Pope J
    Rheumatol Int; 2013 Feb; 33(2):457-65. PubMed ID: 22461187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.
    Humphreys JH; Verheul MK; Barton A; MacGregor AJ; Lunt M; Toes RE; Symmons DP; Trouw LA; Verstappen SM
    Ann Rheum Dis; 2016 Jun; 75(6):1139-44. PubMed ID: 26443608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies.
    Farragher TM; Lunt M; Plant D; Bunn DK; Barton A; Symmons DP
    Arthritis Care Res (Hoboken); 2010 May; 62(5):664-75. PubMed ID: 20461787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disability and quality-of-life are not influenced by the prevalence of autoantibodies in early rheumatoid arthritis patients--results of the Brasília Cohort.
    Mota LM; Santos Neto LL; Burlingame RW; Ménard HA; Pereira IA; Carvalho JF; Laurindo IM
    Rev Bras Reumatol; 2012 Dec; 52(6):824-9. PubMed ID: 23223694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort.
    Arnold MB; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
    Rheumatology (Oxford); 2014 Jun; 53(6):1075-86. PubMed ID: 24501240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between Function and Disease Activity as Measured by the HAQ and DAS28 Varies Over Time and by Rheumatoid Factor Status in Early Inflammatory Arthritis (EIA). Results from the CATCH Cohort.
    Boyd TA; Bonner A; Thorne C; Boire G; Hitchon C; Haraoui BP; Keystone EC; Bykerk VP; Pope JE
    Open Rheumatol J; 2013; 7():58-63. PubMed ID: 24044031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Canadian Early Arthritis Cohort (CATCH): patients with new-onset synovitis meeting the 2010 ACR/EULAR classification criteria but not the 1987 ACR classification criteria present with less severe disease activity.
    Bykerk VP; Jamal S; Boire G; Hitchon CA; Haraoui B; Pope JE; Thorne JC; Sun Y; Keystone EC
    J Rheumatol; 2012 Nov; 39(11):2071-80. PubMed ID: 22896026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Work disability in rheumatoid arthritis--development over 15 years and evaluation of predictive factors over time.
    Eberhardt K; Larsson BM; Nived K; Lindqvist E
    J Rheumatol; 2007 Mar; 34(3):481-7. PubMed ID: 17299844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.
    Shu J; Bykerk VP; Boire G; Haraoui B; Hitchon C; Thorne JC; Tin D; Keystone EC; Pope JE;
    J Rheumatol; 2015 Nov; 42(11):2023-8. PubMed ID: 26329342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.
    Quartuccio L; Fabris M; Salvin S; Atzeni F; Saracco M; Benucci M; Cimmino M; Morassi P; Masolini P; Pellerito R; Cutolo M; Puttini PS; De Vita S
    Rheumatology (Oxford); 2009 Dec; 48(12):1557-9. PubMed ID: 19789202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study.
    Barrett EM; Scott DG; Wiles NJ; Symmons DP
    Rheumatology (Oxford); 2000 Dec; 39(12):1403-9. PubMed ID: 11136885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis.
    Inanc N; Dalkilic E; Kamali S; Kasapoglu-Günal E; Elbir Y; Direskeneli H; Inanc M
    Clin Rheumatol; 2007 Jan; 26(1):17-23. PubMed ID: 16538391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated anticitrullinated protein antibody and rheumatoid factor assessment is not necessary in early arthritis: results from the ESPOIR cohort.
    Gossec L; Paternotte S; Combe B; Meyer O; Dougados M
    J Rheumatol; 2014 Jan; 41(1):41-6. PubMed ID: 24241481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does socioeconomic status affect outcomes in early inflammatory arthritis? Data from a canadian multisite suspected rheumatoid arthritis inception cohort.
    Yang G; Bykerk VP; Boire G; Hitchon CA; Thorne JC; Tin D; Haraoui B; Keystone EC; Pope JE;
    J Rheumatol; 2015 Jan; 42(1):46-54. PubMed ID: 25399388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
    Manivel VA; Mullazehi M; Padyukov L; Westerlind H; Klareskog L; Alfredsson L; Saevarsdottir S; Rönnelid J
    Ann Rheum Dis; 2017 Sep; 76(9):1529-1536. PubMed ID: 28336519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review.
    Barra L; Pope J; Bessette L; Haraoui B; Bykerk V
    Rheumatology (Oxford); 2011 Feb; 50(2):311-6. PubMed ID: 20621983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline patient reported outcomes are more consistent predictors of long-term functional disability than laboratory, imaging or joint count data in patients with early inflammatory arthritis: A systematic review.
    Gwinnutt JM; Sharp CA; Symmons DPM; Lunt M; Verstappen SMM
    Semin Arthritis Rheum; 2018 Dec; 48(3):384-398. PubMed ID: 29680162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort.
    Choy T; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
    Rheumatology (Oxford); 2014 Mar; 53(3):482-90. PubMed ID: 24241035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
    Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
    Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.